Dosimertinib-d3 is a deuterated, orally bioavailable EGFR inhibitor that suppresses p-EGFR and p-ERK signaling. It demonstrates potent antiproliferative activity in vitro and anti-tumor efficacy in vivo, making it a valuable chemical probe for researching EGFR-mutant non-small cell lung cancer (NSCLC).
Molecular Weight:
504.64
CAS Number:
[2403760-70-1]
Formula:
C28H28D5N7O2
Target:
EGFR
* VAT and and shipping costs not included. Errors and price changes excepted
